|
PTPN14 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.217000E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.86290000000167E-05 |
| Normal-vs-Stage2 |
1.677520E-02 |
| Normal-vs-Stage3 |
1.123210E-01 |
| Normal-vs-Stage4 |
3.798000E-01 |
| Stage1-vs-Stage2 |
7.417400E-01 |
| Stage1-vs-Stage3 |
7.452200E-01 |
| Stage1-vs-Stage4 |
6.217400E-01 |
| Stage2-vs-Stage3 |
9.641200E-01 |
| Stage2-vs-Stage4 |
8.537400E-01 |
| Stage3-vs-Stage4 |
8.885600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.826400E-04 |
| Normal-vs-AfricanAmerican |
1.982850E-04 |
| Normal-vs-Asian |
1.5867995806218E-10 |
| Caucasian-vs-AfricanAmerican |
3.010800E-01 |
| Caucasian-vs-Asian |
3.01809999991853E-07 |
| AfricanAmerican-vs-Asian |
1.041230E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.47659999996763E-06 |
| Normal-vs-Female |
3.155200E-01 |
| Male-vs-Female |
1.368270E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.120300E-03 |
| Normal-vs-Extreme_Weight |
8.39100000038506E-07 |
| Normal-vs-Obese |
7.189700E-02 |
| Normal-vs-Extreme_Obese |
6.19349999999574E-05 |
| Normal_Weight-vs-Extreme_Weight |
3.478800E-01 |
| Normal_Weight-vs-Obese |
3.752000E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.266970E-01 |
| Extreme_Weight-vs-Obese |
3.127800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.874200E-01 |
| Obese-vs-Extreme_Obese |
1.415970E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.880600E-01 |
| Normal-vs-Age(41-60Yrs) |
8.195200E-03 |
| Normal-vs-Age(61-80Yrs) |
1.92195999999534E-05 |
| Normal-vs-Age(81-100Yrs) |
4.0051000294028E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.874600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.939220E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.771700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.615600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.54839999999745E-05 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.096900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.403390E-04 |
| Normal-VS-Type2 PRCC |
1.68829999980247E-08 |
| Normal-VS-KIRP CIMP |
1.926380E-01 |
| Normal-VS-Unclassified PRCC |
1.429590E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.877700E-02 |
| Type1 PRCC-VS-KIRP CIMP |
6.325600E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.029600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.936500E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.259700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.014210E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.08369998822411E-09 |
| Normal-vs-N1 |
5.824000E-01 |
| Normal-vs-N2 |
8.702000E-01 |
| N0-vs-N1 |
8.564300E-02 |
| N0-vs-N2 |
4.149000E-01 |
| N1-vs-N2 |
6.797400E-01 |
|
|
